U.S. Diagnostic reports profitable year

Article

Imaging services provider U.S. Diagnostic reported a return to profitability in 1998, a sign that the company's ongoing recovery effort is proving successful. For the year (end-December), USDL of West Palm Beach, FL, reported net income of $4.8 million,

Imaging services provider U.S. Diagnostic reported a return to profitability in 1998, a sign that the company's ongoing recovery effort is proving successful. For the year (end-December), USDL of West Palm Beach, FL, reported net income of $4.8 million, compared with a net loss of $116.7 million in 1997. USDL had revenues for the year of $195.7 million, compared with $216.2 million the year before.

USDL was able to turn a profit on lower revenues by selling off many underperforming imaging centers, according to Joseph Paul, president and CEO. The company also reduced its debt through restructuring in late 1998 and early 1999. USDL's lower debt load and an expected 5% to 7% growth in procedure volume at its centers should help the company improve its performance this year, Paul said.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.